Jacobs Levy Equity Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-193,469
| Closed | -$667K | – | 1088 |
|
|
2020
Q2 | $667K | Buy |
+193,469
| New | +$667K | 0.01% | 741 |
|
|
2015
Q2 | – | Sell |
-27,900
| Closed | -$163K | – | 845 |
|
|
2015
Q1 | $163K | Sell |
27,900
-46,394
| -62% | -$271K | ﹤0.01% | 721 |
|
|
2014
Q4 | $582K | Sell |
74,294
-36,000
| -33% | -$282K | 0.01% | 587 |
|
|
2014
Q3 | $542K | Sell |
110,294
-33,090
| -23% | -$163K | 0.01% | 597 |
|
|
2014
Q2 | $886K | Sell |
143,384
-59,900
| -29% | -$370K | 0.01% | 538 |
|
|
2014
Q1 | $1.09M | Buy |
203,284
+77,694
| +62% | +$416K | 0.02% | 521 |
|
|
2013
Q4 | $657K | Sell |
125,590
-10,400
| -8% | -$54.4K | 0.01% | 664 |
|
|
2013
Q3 | $751K | Buy |
135,990
+42,690
| +46% | +$236K | 0.01% | 595 |
|
|
2013
Q2 | $236K | Buy |
+93,300
| New | +$236K | ﹤0.01% | 870 |
|